- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥28.5b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥61.19
7D
16.7%
1Y
-25.7%
PharmaResources (Shanghai)
Market Cap: CN¥7.0b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥39.06
7D
44.6%
1Y
30.4%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.8b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥26.76
7D
16.7%
1Y
-20.8%
AcrobiosystemsLtd
Market Cap: CN¥14.7b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥88.21
7D
63.5%
1Y
54.1%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.5b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.67
7D
14.5%
1Y
1.8%
Inner Mongolia Furui Medical Science
Market Cap: CN¥12.2b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥46.38
7D
7.7%
1Y
-4.5%